MB

Martina Berto Tbk

MBTO · JK · Consumer Defensive / Household & Personal Products

104.00IDR+2.00 (+1.96%)

Price History

Full chart

Market Stats

Previous Close102.00
Open102.00
Day Range100.00 – 104.00
52-Week Range90.00 – 334.00
Volume849.20K
Market Cap154.08B
P/E (TTM)0.00
Forward P/E0.00
EPS-120.73
Dividend Yield0.00%
Beta0.35
50-Day Avg137.36
200-Day Avg132.67

About

PT Martina Berto Tbk, together with its subsidiaries, manufactures, markets, sells, and trades in cosmetics and traditional medicines in Indonesia and internationally. It operates in two segments, Cosmetics and Herbal Medicine. The company offers facial cleansers, toners, moisturizers, liquid foundations, body splash colognes, hair sprays, and other liquid formulations; eye shadow, blush on, loose powder, compact powder, and other powder-based products; lipsticks, creamy foundations, and other semi-solid formulations; and masks, body scrubs, herbal teas, and mangir and other natural-based products. It sells its products under the Sariayu Martha Tilaar, Dewi Sri Spa Martha Tilaar, Biokos Martha Tilaar, Caring Colours by Martha Tilaar, Martha Tilaar Professional Artist Cosmetics, Belia Martha Tilaar, Rudy Hadisuwarno Cosmetics, Mirabella, and Cempaka brands. PT Martina Berto Tbk was founded in 1977 and is headquartered in Jakarta, Indonesia. PT Martina Berto Tbk operates as a subsidiary of PT Marthana Megahayu Inti.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Bryan David Emil
  • Employees296
  • HeadquartersJl Pulo Kambing II no.II, Jakarta, Indonesia, 13930, Indonesia
  • Websitehttps://www.martinaberto.co.id

Leadership

  • Mr. Bryan David EmilPresident Director · b. 1976
  • Mr. Iwan SetiadiHead of Finance & Administration · b. 1970
  • Mr. Johanes ChrismantoHead of Internal Audit
  • Katerine Rosdeny-MailyHead of Research & Development
  • Ida HidayatiHead of Manufacturing
  • Yuddy Dermawan RohmadHead of Corporate Social Responsibility
  • Mr. Muhammad Shabri HasanCorporate Secretary

Financials

Income Statement

Currency: IDR2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue334.95B429.88B516.32B566.19B648.38B717.79B641.28B671.40B694.78B685.44B731.58B502.52B537.57B297.22B210.53B360.18B418.53B431.60B401.54B
Growth (%)-+28.34%+20.11%+9.66%+14.52%+10.71%-10.66%+4.70%+3.48%-1.34%+6.73%-31.31%+6.97%-44.71%-29.17%+71.09%+16.20%+3.12%-6.97%
Cost of Revenue150.22B196.45B241.81B256.70B293.34B342.73B315.41B331.72B361.40B340.60B370.81B303.36B317.91B215.19B160.37B236.93B274.84B268.93B253.47B
Gross Profit-----375.06B325.87B339.67B333.38B344.85B360.76B199.16B219.66B82.03B50.16B123.25B143.68B162.68B148.07B
Gross Margin-----52.25%50.82%50.59%47.98%50.31%49.31%39.63%40.86%27.60%23.82%34.22%34.33%37.69%36.88%
Operating Expense-----320.98B304.34B330.02B341.90B320.19B381.32B334.15B282.03B248.46B140.90B149.54B146.20B143.42B152.16B
Operating Income11.56B14.87B27.90B51.75B46.90B54.08B21.54B9.66B-8.52B24.66B-20.55B-134.99B-62.37B-166.44B-90.74B-26.29B-2.52B19.26B-4.10B
Operating Margin3.45%3.46%5.40%9.14%7.23%7.53%3.36%1.44%-1.23%3.60%-2.81%-26.86%-11.60%-56.00%-43.10%-7.30%-0.60%4.46%-1.02%
EBITDA-----77.20B38.69B29.15B15.32B52.84B12.43B-109.13B-42.25B-138.18B-68.01B-7.84B9.10B35.87B11.52B
EBITDA Margin-----10.76%6.03%4.34%2.21%7.71%1.70%-21.72%-7.86%-46.49%-32.30%-2.18%2.17%8.31%2.87%
Net Income---36.76B42.66B45.52B16.16B4.21B-14.06B8.81B-24.69B-114.13B-66.95B-203.22B-149.74B-42.43B-31.93B-4.46B-27.80B
Net Income Margin---6.49%6.58%6.34%2.52%0.63%-2.02%1.29%-3.38%-22.71%-12.45%-68.37%-71.12%-11.78%-7.63%-1.03%-6.92%
Interest Expense000000007.38B13.09B14.82B17.85B20.43B21.28B19.03B16.42B17.60B18.79B18.13B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.06%1.91%2.03%3.55%3.80%7.16%9.04%4.56%4.20%4.35%4.52%

Balance Sheet

Currency: IDR2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets263.52B279.40B276.87B333.13B541.67B609.49B611.77B623.00B650.33B709.96B780.67B648.02B591.06B982.88B713.52B721.70B673.25B669.38B640.32B
Total Liabilities174.38B188.07B186.18B216.21B141.13B174.93B160.45B180.11B216.12B269.03B367.93B347.52B355.89B393.02B269.19B316.91B304.11B301.96B300.73B
Total Equity89.14B90.94B90.69B116.92B398.97B434.54B451.29B442.89B434.21B440.93B412.74B300.50B235.17B589.86B444.33B404.79B369.13B367.41B339.57B
Cash14.04B15.94B12.52B12.76B189.42B119.51B47.59B41.26B30.92B6.59B5.24B4.00B2.64B2.20B2.85B4.02B4.47B4.44B4.82B
Total Debt------53.70B33.90B43.72B101.99B161.14B169.65B186.92B195.44B142.76B161.39B168.11B172.44B159.92B
Net Debt------119.51B6.11B-7.36B12.80B95.39B155.90B165.65B184.29B193.24B139.90B157.37B163.64B167.99B155.10B

Cash Flow

Currency: IDR2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.52B20.98B41.97B16.18B20.62B-13.92B-2.86B1.67B1.01B4.90B-33.05B6.59B-9.62B1.38B-127.31B-12.70B3.36B6.80B18.65B
Investing Cash Flow------51.25B-87.28B12.54B-16.96B-77.40B-19.99B-13.50B-2.04B134.92M181.99B-4.77B-6.22B-2.81B-3.45B
Financing Cash Flow----177.73B-4.74B18.23B-20.54B5.61B48.18B51.69B5.66B10.30B-1.95B-54.03B18.64B3.30B-4.01B-14.82B
Capital Expenditure0011.83B14.33B25.42B23.96B66.17B36.41B17.86B80.00B24.62B15.68B4.20B8.82B1.43B2.88B2.86B4.19B4.13B
Free Cash Flow------37.88B-69.04B-34.74B-16.84B-75.10B-57.67B-9.09B-13.82B-7.44B-128.74B-15.58B502.31M2.61B14.51B
Dividends Paid--31.00B30.60B10.70B10.70B-------------
FCF to OCF-----272.08%2410.73%-2080.47%-1665.82%-1533.91%174.49%-137.87%143.71%-540.55%101.12%122.68%14.95%38.34%77.84%
Dividend Paid to FCF------28.24%-------------

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate-------------------------------------------------
EPS Actual9.3513.0110.1210.1212.7511.558.126.6310.3011.07-12.892.331.29-1.170.282.412.49-2.33-15.727.130.580.430.100.782.43-27.831.540.45-20.68-37.96-48.470.80-16.85-9.84-36.67-22.66-18.46-35.86-112.95-22.10-24.61-15.44-76.89-3.79-13.220.54-23.18-0.41-3.23
Surprise-------------------------------------------------
Timing-------------------------------------------------

Key Statistics & Ratios

Market Cap154.08B
Enterprise Value165.85B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.33
Price / Book0.00
EPS-120.73
Book Value329.51
Revenue (TTM)469.36B
Gross Profit (TTM)179.76B
EBITDA39.58B
Profit Margin0.32%
Operating Margin7.20%
Return on Equity0.42%
Return on Assets2.61%
Shares Outstanding1.07B
Shares Float349.28M
Beta0.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20121×
10.00Jun 28, 2012
20111×
10.00Jul 6, 2011